Labatt Family Heart Centre, Division of Pediatric Cardiology, Department of Pediatrics, University of Toronto, Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada.
Department of Paediatric Pulmonary and Critical Care, Amrita Institute of Medical Sciences, Kochi, India.
Pediatr Cardiol. 2023 Dec;44(8):1839-1846. doi: 10.1007/s00246-023-03242-6. Epub 2023 Jul 31.
Unplanned reinterventions following pulmonary artery banding (PAB) in single ventricle patients are common before stage 2 palliation (S2P) but associated risk factors are unknown. We hypothesized that reintervention is more common when PAB is placed at younger age and with a looser band, reflected by lower PAB pressure gradient. Retrospective single center study of single ventricle patients undergoing PAB between Jan 2000 and Dec 2020. The association with reintervention and successful S2P was modeled using exploratory cause-specific hazard regression. A multivariable model was developed adjusting for clinical and statistically relevant predictors. The cumulative proportion of patients undergoing reintervention were summarized using a competing risk model. 77 patients underwent PAB at median (IQR) 47 (24-66) days and 3.73 (3.2-4.5) kg. Within18 months of PAB, 60 (78%) reached S2P, 9 (12%) died, 1 (1%) transplanted and 7 (9%) were alive without S2P. Within 18 months of PAB 10 (13%) patients underwent reintervention related to pulmonary blood flow modification: PAB adjustment (n = 6) and conversion to Damus-Kaye-Stansel/Blalock-Taussig-Thomas shunt (n = 4). 6/10 (60%) reached S2P following reintervention. A trend toward higher intervention in patients with a genetic syndrome (p-0.06) and weight < 3 kg (p-0.057) at time of PAB was noted. Only genetic syndrome was a risk factor associated with poor outcome (p-0.025). PAB has a reasonable outcome in SV patients with unobstructed systemic and pulmonary blood flow, but with a high reintervention rate. Only a quarter of patients with genetic syndromes reach S2P and further study is required to explore the benefits from an alternative palliative strategy.
在进行二期姑息治疗(S2P)之前,肺动脉带(PAB)后进行的单心室患者的非计划性再干预是很常见的,但相关的危险因素尚不清楚。我们假设,当 PAB 放置在更年轻的年龄和更宽松的乐队时,再干预更为常见,这反映了较低的 PAB 压力梯度。对 2000 年 1 月至 2020 年 12 月期间接受 PAB 的单心室患者进行的回顾性单中心研究。使用探索性因果风险回归模型对再干预和成功 S2P 的相关性进行建模。建立了多变量模型,以调整临床和统计学上相关的预测因素。使用竞争风险模型总结患者接受再干预的累积比例。77 名患者在中位数(IQR)47(24-66)天和 3.73(3.2-4.5)kg 时接受 PAB。在 PAB 后 18 个月内,60(78%)达到 S2P,9(12%)死亡,1(1%)移植,7(9%)无 S2P 存活。在 PAB 后 18 个月内,10 名(13%)患者因肺血流量修改而接受再干预:PAB 调整(n=6)和转换为 Damus-Kaye-Stansel/Blalock-Taussig-Thomas 分流术(n=4)。6/10(60%)在再干预后达到 S2P。在 PAB 时患有遗传综合征(p-0.06)和体重<3kg(p-0.057)的患者中,干预的趋势较高。只有遗传综合征是与不良结局相关的危险因素(p-0.025)。在 SV 患者中,PAB 具有通畅的体循环和肺循环,但再干预率较高,结果合理。只有四分之一的遗传综合征患者达到 S2P,需要进一步研究以探讨替代姑息治疗策略的益处。